Medicare Enrolled

Dr. Ali Azizzadeh Fard, M.D.

Surgery · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
6410 FANNIN ST, Houston, TX 77030
7135005304
In practice since 2006 (19 years)
NPI: 1780618918 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Azizzadeh Fard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Azizzadeh Fard? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Azizzadeh Fard

Dr. Ali Azizzadeh Fard is a surgery in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Azizzadeh Fard performed 1,386 Medicare services across 1,340 unique beneficiaries.

Between the years covered by Open Payments, Dr. Azizzadeh Fard received a total of $225,834 from 40 pharmaceutical and/or device companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Azizzadeh Fard is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 6% volume in TX$ $225,834 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,386
Medicare services
Top 6% in TX for surgery
1,340
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~73 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Ultrasound study of arm or leg veins with compression and maneuvers450$27$107
Ultrasound study of one arm or leg veins with compression and maneuvers226$17$69
Ultrasound of both sides of head and neck blood flow140$30$123
Ultrasound study of arm and leg arteries111$10$38
Initial hospital admission, moderate complexity83$109$425
Ultrasound of leg arteries or artery grafts59$30$120
Complete ultrasound study of arm and leg arteries55$17$69
Ultrasound of hemodialysis access49$17$74
Ultrasound of one leg arteries or artery grafts38$19$74
Complete ultrasound of abdomen and pelvis artery and vein blood flow33$43$277
Ultrasound of abdomen and pelvis artery and vein blood flow33$33$176
Removal of blood clot and portion of chest, neck, or brain artery21$873$3,814
Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance18$213$1,277
Exposure of groin artery for delivery of graft16$74$505
Review by radiologist of abdominal aorta image15$56$212
Ultrasound scan of abdominal aorta14$28$97
Ultrasound of one arm arteries or artery grafts13$20$74
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes12$71$316
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$225,834
Total received (2018-2024)
Avg $32,262/year across 7 years
Top 1% in TX for surgery
40
Companies
586
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$148,965 (66.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$57,837 (25.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,032 (8.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$24,268
2023
$8,209
2022
$36,454
2021
$18,054
2020
$11,722
2019
$43,471
2018
$83,654

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
W. L. Gore & Associates, Inc.
$116,796
Medtronic Vascular, Inc.
$63,609
Medtronic, Inc.
$28,918
Cook Medical LLC
$3,492
Penumbra, Inc.
$2,035
Silk Road Medical, Inc.
$1,950
Bolton Medical Inc
$1,598
Boston Scientific Corporation
$964
Smith+Nephew, Inc.
$919
Inari Medical, Inc.
$611
Okami Medical, Inc.
$482
Abbott Laboratories
$445
Bard Peripheral Vascular, Inc.
$354
ShockWave Medical, Inc
$349
Terumo Medical Corporation
$333
Osiris Therapeutics Inc.
$269
LeMaitre Vascular, Inc.
$241
Cagent Vascular INC
$234
Endologix, Inc.
$234
Endologix LLC
$200
Walk Vascular, LLC
$198
Edwards Lifesciences Corporation
$173
Surmodics, Inc.
$172
Maquet Cardiovascular U.S. Sales, L.L.C.
$141
TRUVIC MEDICAL, INC.
$130
Baxter Healthcare
$123
ACELL, INC.
$117
Amgen Inc.
$111
Acacia Pharma Inc
$96
REVANCE THERAPEUTICS, INC.
$86
AngioDynamics, Inc.
$83
Shape Memory Medical Inc.
$73
Becton, Dickinson and Company
$66
HeartFlow, Inc.
$52
Baylis Medical Technologies Inc.
$44
Paratek Pharmaceuticals, Inc.
$42
BOSTON SCIENTIFIC CORPORATION
$28
Siemens Medical Solutions USA, Inc.
$25
Philips Electronics North America Corporation
$25
Imperative Care, Inc
$19
Top 3 companies account for 92.7% of total payments
Associated products mentioned in payments ›
(9556) IVC Filter Removal · ABRE · ABSORB · AZUR · Absorb GT1 · Alto Abdominal Stent Graft System · Apollo · Aptus Heli-FX · Azur CX Detachable · BYFAVO · C3 Delivery System · CHAMELEON · COOK · COOK MEDICAL THORACIC · COOK MEDICAL ZILVER PTX · CT THROMBECTOMY SYSTEM KIT · Concerto · Conformable TAG Thoracic Endoprosthesis · Cook Medical AAA · Cook Medical Stents · Cook Medical Thoracic · Cook Medical Zenith · DAXXIFY · DxTerity · ELUVIA · ENDURANT IIS · ENROUTE .014 Guidewire · ENROUTE Transcarotid Neuroprotection System · ENROUTE Transcarotid Stent · ESPRIT · EXCLUDER AAA Endoprosthesis · EXCLUDER Conformable AAA Endoprosthesis with Active Control · EXCLUDER Iliac Branch Endoprosthesis · Endurant · FFRct · FLIXENE · FLOWTRIEVER CATHETER · FLUENCY · GENERAL METALLIC STENTS · GENERAL ATHERECTOMY · GENERAL IO ABLATION · GORE DRYSEAL Sheath · GORE EXCLUDER AAA Endoprosthesis · GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis · GORE TAG Conformable Thoracic Endoprosthesis · GORE TAG Conformable Thoracic Stent Graft · GORE TAG Thoracic Branch Endoprosthesis · GORE TAG Thoracic Endoprosthesis · GORE VIABAHN Endoprosthesis with Heparin · GORE VIABAHN VBX Balloon Expandable Endo · GORE-TEX Vascular Graft · GRAFIX/GRAFIXPL/STRAVIX · General - Vascular Intervention · Grafts · HELI-FX ENDOANCHOR SYSTEM · HYDRO LEMAITRE VALVULOTOME · IMPEDE EMBOLIZATION PLUG · IN.PACT Admiral · Indigo · Indigo System · JETi All In One Non-Sterile Kit · LOBO · LUTONIX Drug Coated Balloon · NUZYRA · OASIS · OptiCross 35 · PREVELEAK · PRODIGY CATHETER · Penumbra Ruby Coil · Penumbra System · Perclose ProGlide suture mediated closure system · Pounce Thrombectomy System · Product in Development · RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM · RUBY Coil · Ranger · Relay Grafts · Relay Plus · Repatha · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · STRAVIX · Serrantor · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Stents · Stravix · TAG Thoracic Endoprosthesis · TREO ABDOMINAL STENT-GRAFT SYSTEM · VALIANT CAPTIVIA · VALIANT NAVION · VENACURE 1470 PRO · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VIABAHN Endoprosthesis with PROPATEN Bioactive Surface · VIABAHN VBX Balloon Expandable Endoprosthesis · Valiant Captivia · Valiant Navion · ZENITH ALPHA · ZENITH SPIRAL-Z · ZILVER PTX · Zenith · iCAST
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in surgery and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for surgery in TX.

Equivalent to $16,294 per 100 Medicare services performed
Looking for a surgery in Houston?
Compare surgerys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse surgerys nearby

Geographic Context

Surgerys within 10 mi
525
Per 100K population
11.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Azizzadeh Fard is a mixed practice specialist, with above-average Medicare volume (top 6% in TX), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Azizzadeh Fard experienced with ultrasound study of arm or leg veins with compression and maneuvers?
Based on Medicare claims data, Dr. Azizzadeh Fard performed 450 ultrasound study of arm or leg veins with compression and maneuvers services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Azizzadeh Fard receive payments from pharmaceutical companies?
Yes. Dr. Azizzadeh Fard received a total of $225,834 from 40 companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Azizzadeh Fard's costs compare to other surgerys in Houston?
Dr. Azizzadeh Fard's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Azizzadeh Fard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →